Synchronous carotid artery stenting and open heart surgery  by Velissaris, Ioannis et al.
Synchronous carotid artery stenting and open
heart surgery
Ioannis Velissaris, MD, Dimitrios Kiskinis, MD, and Kyriakos Anastasiadis, MD, Thessaloniki, Greece
Background: The optimal management of the patients requiring cardiac surgery with concomitant severe carotid disease
remains a controversy. The traditional approach involves staged or combined carotid endarterectomy and cardiac surgery.
This study evaluated the feasibility and safety of angioplasty and stenting for the treatment of carotid stenoses
concomitantly to cardiac operations to reduce the risk of perioperative stroke.
Methods: All patients scheduled for cardiac surgery were screened preoperatively by color duplex ultrasonography for
carotid disease. Carotid stenoses >60% in symptomatic patients and >70% in asymptomatic patients were treated using
carotid artery stenting (CAS) under local anesthesia immediately before the open heart surgery. Cerebral protection
devices were used in all cases. Patients did not receive aspirin or clopidogrel before the procedure. In a prospective,
nonrandomized study, we analyzed 90 consecutive patients requiring cardiac surgery with concomitant severe carotid
artery disease who underwent one stage CAS and cardiac surgery.
Results:Despite the high baseline risk profile, our results were encouraging. Carotid stenting was successful in all patients.
No neurologic complications occurred during the carotid stenting procedures. The 30-day death/stroke rate was 2.2%
(one death, one contralateral stroke). No myocardial infarction occurred. The carotid restenosis rate was zero during the
intermediate-term follow-up.
Conclusions: In our experience, CAS followed immediately by cardiac surgery is safe and represents a reasonable option for
selected patients presenting with severe carotid and coronary disease. ( J Vasc Surg 2011;53:1237-41.)
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oCarotid artery stenosis is a well-known risk factor for
perioperative stroke in cardiac surgery.1-6 The optimal
management of the patients requiring cardiac surgery with
simultaneous severe carotid disease remains controversial
and debated. Various potential therapeutic options exist.
Evidence suggests that carotid endarterectomy (CEA)
should be performed before cardiac surgery as a staged or
simultaneous operation to reduce the risk of perioperative
stroke.6-12 There is also literature claiming that such pa-
tients need no carotid intervention at all in conjunction
with their coronary bypass procedures.13-15
In our institute, before this study, our strategy with
these patients was combined carotid/cardiac surgery. Even
though our results have been acceptable (9% rate of death,
stroke or myocardial infraction at 30 days), we thought that
we could use carotid artery angioplasty with stenting (CAS)
instead of CEA to achieve similar goals. Carotid angioplasty
with cerebral protection followed immediately by cardiac
surgery might represent a less invasive and safer option that
could be associated with fewer complications. We chose the
one stage approach to avoid the problems and potential
complications of the staged approach, due to delay of
coronary bypass and early cessation of antiplatelet therapy
after CAS and before surgery.
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atient population
In a prospective, nonrandomized study, we analyzed
0 consecutive patients that underwent one stage CAS and
ardiac surgery from September 2003 to March 2010 at
ur center. The study protocol was approved by the Ethics
ommittee of our hospital and all patients gave written
nformed consent. The baseline characteristics of all pa-
ients are shown in Table I.
The indications for cardiac surgery were established
efore the carotid angioplasty. At our center, all patients
cheduled for cardiac surgery are screened preoperatively by
olor duplex ultrasonography for carotid disease. The esti-
ation of the degree of carotid stenosis is based on Nico-
aides criteria.16 Our policy is to treat symptomatic patients
ith60% carotid stenosis and asymptomatic patients with
70% stenosis. If both carotid arteries are involved, we
reat the symptomatic side or the side with the more severe
tenosis in asymptomatic patients. During the study period,
239 consecutive cardiac surgery patients were screened
nd 103 of them fulfilled the selection criteria for carotid
reatment.
Since September 2003, our standard strategy was to
reat significant carotid stenosis by percutaneous angio-
lasty and stenting in patients requiring cardiac surgery.
arotid endarterectomy was used in patients excluded from
he protocol or for those who did not provide informed
onsent. All patients were informed that in the case of
nsuccessful carotid angioplasty, they would be treated by
ynchronous carotid endarterectomy/cardiac surgery with-
ut delay.
The endovascular procedure was performed by the
uthors (vascular surgeons) immediately before open heart
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May 20111238 Velissaris et alsurgery. The patients with unstable angina, active chest
pain, or left main stem stenosis underwent CAS in the
cardiac operating room using a C-arm. Stable patients
underwent CAS in the catheterization laboratory and were
transferred to the operating room after the procedure. The
endovascular procedure was performed under local anes-
thesia with femoral access and was followed by induction of
general anesthesia and cardiac surgery. The severity of
carotid and cardiac disease is shown in Table II.
During the study period, we performed 13 carotid
endarterectomies simultaneously with cardiac surgery.
Nine of them were patients excluded from CAS; serum
creatinine 3 mg/dL (one patient), history of allergic
reaction to contrast medium (one patient), extreme tortu-
osity of brachiocephalic trunk (one patient), type III calci-
fied aortic arch (three patients), complex anatomy of ca-
rotid bifurcation (two patients), and kinking of internal
carotid artery (one patient). Four patients chose the com-
bined CEA/cardiac surgery treatment.
The endpoint of the study was the combined inci-
dence of death and stroke from the day of procedure to
30 days later. The secondary endpoint was myocardial
infarction (MI) during the same period. A stroke was
defined as a new focal neurologic deficit that persisted
24 hours. Transient ischemic attack was diagnosed if
Table 1. Baseline characteristics of the patients
Mean age 69.6 (54-85)
Men 68 (75.5%)
Current smoking 33 (37%)
Hypertension 68 (76%)
Diabetes mellitus 49 (54.5%)
Lipidemia 43 (48%)
Family history 30 (33%)
Table II. Severity of carotid and cardiac disease
Degree of treated carotid stenosis
60%-79% 31 (34.5%)
80%-89% 26 (29%)
90%-99% 33 (36.5%)
Degree of contralateral carotid stenosis
occluded 15 (17%)
50% 24 (26.5%)
50% 51 (56.5%)
Symptomatica 12 (13.3%)
Asymptomatic 78 (86.6%)
CAD
3 vessel disease 68 (75.5%)
Left main stem disease 23 (25.5%)
Unstable angina pectoris 13 (14.5%)
Previous CABG 6 (6.6%)
Valvular disease alone 0
Valvular disease  CAD 15 (16.6%)
Poor LV function (EF25%) 15 (16.6%)
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; EF,
ejection fraction; LV, left ventricular
aStroke or transient ischemic attack or amaurosis fugax in the 12 months
prior to CAS.the duration of symptoms lasted 24 hours. The diag- posis of MI was based on the presence of new Q waves on
he electrocardiogram (ECG) and new regional wall
otion abnormalities on the postoperative cardiac ultra-
onography. The elevated level of creatine phosphoki-
ase myocardial isoenzyme (CPK-MB) and troponin
ere also used for the diagnosis of MI.
AS procedure
Patients did not receive aspirin or clopidogrel before
he procedure and were not sedated during the procedure.
rterial access was obtained through the femoral artery in
ll cases, using local anesthesia. A 7 or 8F introducer sheath
as inserted followed by intravenous heparin administra-
ion (5000 IU).
The first step was to obtain an angiogram of the aortic
rch, the carotid arteries, and the intracranial circulation to
onfirm the degree of carotid stenosis and identify possible
natomical contraindications for CAS. The degree of ste-
osis was calculated according to the North American
ymptomatic Carotid Endarterectomy Trial (NASCET)
ethodology.17
A 7 or 8F preshaped angioplasty guiding catheter was
sed to ensure access to the common carotid artery. All
rocedures were done under embolic protection. Four
ifferent cerebral protection devices were used: Accunet
ystem (Abbott Vascular, Abbott Park, Ill), Emboshield
ystem (Abbott Vascular), FilterWire system (Boston Sci-
ntific, Natick, Mass), and MO.MA device (Invatec, Ron-
adelle, Italy). When necessary, an undersized angioplasty
alloon was used (3.0-3.5 mm) to predilate the lesion. This
as followed by placement of an appropriately sized stent.
n our series, three different types of carotid tapered nitinol
tents were used: Acculink (Abbott Vascular; an open cell
tent), Xact (Abbott Vascular; a closed cell stent), and
ristallo (Invatec; a closed cell in the middle and open cell
t the edges stent). The choice of the type of filter/stent
epended on the anatomy of the vessels and the carotid
laque characteristics.18,19 After stent placement, atropine
0.5 mg) was administered and postdilation was performed
ith a 5 or 5.5 mm balloon.
Upon completion of the procedure, carotid and intra-
ranial angiography was performed to check the success of
he carotid stenting and to exclude distal embolization.
mmediately after the procedure, patients were evaluated
linically by a neurologist. If there was no evidence of any
eurologic complications, the patients received general an-
sthesia for the subsequent cardiac surgery.
ardiac surgical procedure
Details of the cardiac operations are given in Table III.
ostoperative care
After CAS and cardiac surgery all patients were admit-
ed to the intensive care unit (ICU). In the absence of a
ontraindication (ie, bleeding), aspirin (1g intravenously)
as administered. When the activated clotting time was
180 the femoral introducer sheath was removed. All
atients received 75 mg clopidogrel and 100 mg aspirin
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Volume 53, Number 5 Velissaris et al 1239daily from the first postoperative day on, for at least 1 year.
In addition, all patients were permanently placed on a statin
drug. On the first postoperative day, patients were exam-
ined again by a neurologist for evidence of new neurologic
deficits. Measurement of serum CPK-MB and troponin
levels and a 12-lead ECGwas performed daily. Each patient
had a pre- and postoperative echocardiography evaluation.
Follow-up. Patients were followed from the day of
operation to 30 days after discharge. In patients not avail-
able for clinical examination at 30 days, follow-upwasmade
by telephone interview. Thereafter, carotid arteries were
examined by color duplex ultrasonography at 6-month
intervals. The mean follow-up per patient was 29 months
(range 6-78 months).
RESULTS
Carotid stenting was technically successful in all pa-
tients (good final angiographic result, residual stenosis less
than 15%). After the diagnostic angiogram (the first step of
the CAS procedure), seven patients were excluded from
CAS for anatomical reasons. Instead, they promptly re-
ceived synchronous CEA/cardiac surgery under general
anesthesia. These seven patients were not included in the
study (see patient population in Methods section).
In all cases, duplex criteria for grading carotid stenosis
correlated with angiographic measurements, in terms of the
selection for carotid treatment degree of stenosis. In the
treatment group, there were some differences between
duplex and angiography regarding the exact assessment of
stenosis. We noticed a trend for underestimation of high
grade stenoses by duplex sonography. The degree of
treated carotid stenoses given in Table II, are those mea-
sured on angiogram using the NASCET methodology.
As mentioned before, embolic protection devices were
used in all patients. Entrapped visible debris was found in
nine (10%) procedures. The 30-day incidence of death,
stroke, and MI is listed in Table IV.
The single stroke was a minor event presented as a mild
left-sided hemiparesis in a male patient who underwent
stenting of the left carotid artery (95% stenosis, asymptom-
atic). The degree of stenosis of his right nontreated carotid
artery was 60%. He recovered completely within 30 days. A
separate patient had a different neurologic event; suffering
mild strength reduction of the left hand. This occurred in a
Table III. Cardiac operations (total 90)
Coronary artery bypasses
1 7
2 14
3 28
4 34
5 7
Aortic valve replacement  CABG 10
Mitral valve surgery  CABG 5
Off pump 10
CABG, Coronary artery bypass grafting.male patient who underwent stenting of the right carotid Trtery and resolved within 24 hours (transient ischemic
ttack). In both patients, there was no evidence of a neu-
ologic event after CAS before the open heart procedure.
he neurologic deficits presented after waking from general
nesthesia in the ICU.
No MIs happened during or after the combined treat-
ent. One patient died 15 days after the procedures and 6
ays after discharge due to massive pulmonary embolism,
ccording to the necrotomy report.
In hospital stay was 8.9  3.1 days and was no longer
han the mean stay of the patients who had only cardiac
urgery. All patients followed with serial duplex ultrasound
canning for a mean of 29 months. The restenosis rate was
ero. In four cases, in-stent hyperplasia found without
emodynamic sequel or stenosis.
ISCUSSION AND CONCLUSIONS
Major changes in the revascularization strategies of
ymptomatic obstructive coronary artery disease have been
een in the past decade with a substantial shift toward
ercutaneous coronary intervention, mainly in patients
ith a single- or double-vessel disease on coronary angiog-
aphy.20 Nevertheless, coronary artery bypass grafting
CABG) remains the standard of care for patients with
hree-vessel or left main coronary disease and is preferred in
iabetics.21 Despite the bad risk profile of the patients
eferred for CABG, our results with CAS and CABG in-
tead of CEA and CABG are encouraging. In our series, the
eath/stroke/MI rate was lower than the rate reported by
everal previously published series of combined or staged
ndarterectomy and cardiac surgery.8,11,22,23
Our findings concur with those of previous published
tudies that CAS may provide a safer option for a challeng-
ng patient population, ie, patients with comorbid or ana-
omic features that place them at increased risk for carotid
urgery. The Stenting and Angioplasty with Protection in
atients at High Risk for Endarterectomy (SAPPHIRE)
rial demonstrated a significantly higher incidence of MI
ith CEA than with CAS in a high risk CEA population.24
substantial proportion of SAPPHIRE population had
ardiac/coronary comorbidities. Additionally, previously
ublished studies showed that CAS followed by open heart
urgery is a safer approach than combined CEA and cardiac
urgery.25-27 The explanation for the fewer adverse events
n patients who underwent CAS instead of CEA is not clear.
able IV. Thirty-day incidence of death, stroke, TIA,
nd MI
Death 1 (1.1%)
Stroke 1 (1.1%)
TIA 1 (1.1%)
MI 0
Death or stroke 2 (2.2%)
Death or stroke or MI 2 (2.2%)
I, Myocardial infraction; TIA, transient ischemic attack.he longer operating time and greater duration of general
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trauma in CAS were probably the most important factors.
To our knowledge, this is the third study on the use of
CAS immediately before cardiac surgery (one stage) in the
management of simultaneous severe carotid and cardiac
disease. Mendiz et al and Versaci et al published the results
of CAS/immediate cardiac surgery under aspirin in 30 and
37 patients, respectively, and showed the feasibility and
safety of this method.28,29 In these two studies, patients
received oral aspirin pre-CAS and there were concerns
about bleeding during or following CABG. Cardiac tam-
ponade and chest reopenings for post-CABG bleeding have
been reported in patients receiving antiplatelet agents.28-30
In the absence of randomized clinical trials for the optimal
use of medications in patients undergoing CAS,31 we de-
cided, in our series, to perform CAS with no antiplatelet
pretreatment, to avoid the above-mentioned bleeding
complications.
In Ziada et al series, CAS was performed 39  22 days
before surgery and clopidigrel was stopped 1 week before
surgery.25 InVanderHeyden et al study,CASwas performed
14 to 30 days before surgery and aspirin/clopidogrel was
discontinued 5 days before cardiac surgery.26 Our opinion is
that, in these patients, the antiplatelet agents should not be
stopped during the early poststenting period because it may
cause complications from carotid or coronary arteries. On
the other hand, the delay of CABG in patients with unsta-
ble angina, left main, or multivessel coronary artery disease,
is not a safe policy. Cardiac causes of death have been
reported while patients wait their cardiac bypass proce-
dure.32 The disadvantages of staged treatment can be
avoided using the one stage treatment strategy. In a series
of 37 patients, Kramer et al studied an intermediate ap-
proach where patients had CABG within 48 hours after
CAS. These patients were on a continuous infusion of
eptifibatide for antiplatelet therapy during the interval be-
tween procedures.33 In a systematic review and meta-
analysis of staged CAS and CABG, Naylor et al presented
the 30-day outcomes of the particular strategy; the overall
mortality rate was 5.5% and the risk of suffering any stroke
was 4.2%, while the risk of MI was only 1.8%. The 30-day
rate of death/any stroke was 9.1%, while the combined risk
of death/stroke/MI was 9.4%.34
In our series, the vast majority of the treated patients
are asymptomatic (87%) regarding the carotid disease. The
benefit from invasive treatment in asymptomatic patients
with 70% carotid stenosis is well documented, provided
the rate of periprocedural stroke and death is 3% or less and
life expectancy is at least 5 years.35-37 Thus, carotid treat-
ment is beneficial to these patients, and this is independent
of the need for cardiac surgery. Furthermore, a policy of
screening all patients prior to open heart surgery can reveal
an unknown severe carotid disease and may contribute to
stroke prevention, not only in conjunction with the CABG.
To maintain a low rate of CAS-associated complica-
tions, two parameters are very important; the practitioners’
experience and the patient selection. Our team, which
consists of vascular surgeons, has performedmore than 500arotid interventions. One also must consider that CAS is
ot the best option for all patients with severe carotid
tenosis. Those with complex vessel anatomy, renal failure,
nd difficult arterial access, should be excluded from endo-
ascular treatment. Furthermore, a “tailored technique” is
andatory: by the choice of the right cerebral protection
evice and the appropriate stent a safer procedure may be
erformed. Although there are no randomized studies
omparing CAS with and without embolic protection de-
ices, consensus among experts suggests their use in reduc-
ng the risk of stroke during CAS.37,38 In International
arotid Stenting Study (ICSS) protection devices were
ssociated with a higher risk for new ischemic lesions on
iffusion-weighted brain scans after CAS.39 Nevertheless,
he results of the study should be critically considered,
ecause the ICSS trial had unacceptably low requirements
n terms of endovascular expertise (minimum ten CAS
rocedures in a lifetime versus minimum 50 carotid opera-
ions) and allowed for CAS procedures under tutoring
onditions.
The present study provides further guidance for the
ecision-making process in the management of patients
ith simultaneous severe carotid artery disease and cardiac
isease requiring surgery. The low complication rate sug-
ests that one stage CAS and cardiac surgery may offer a
afer therapeutic option compared with the entirely surgical
pproach. It may also be safer than with the staged CAS and
ABG approach as well. The limitations of our nonran-
omized study are recognized, but these data add to the
imited world literature on carotid stenting immediately
efore cardiac surgery. We accept that further studies are
eeded as only correctly powered randomized trials can
ive definitive answers about the most appropriate strategy.
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